Silent myocardial ischemia: Recent developments

被引：8

作者：

Cohn P.F. ^{[1
]}

机构：

[1] Cardiology Division, Stony Brook University Hospital, Health Sciences Center, Stony Brook

来源：

Current Atherosclerosis Reports | 2005年 / 7卷 / 2期

关键词：

Cardiol; Holter Monitoring; Silent Myocardial Ischemia; Multiple Risk Factor Intervention Trial; Silent Ischemia;

D O I：

10.1007/s11883-005-0039-8

中图分类号：

学科分类号：

摘要：

Silent myocardial ischemia is now in its fourth decade of recognition as a clinical syndrome within the spectrum of coronary artery disease. Prior decades have seen important research into the pathophysiology, detection, prevalence, prognosis, and therapy of this syndrome. More recent developments have continued to add data to each of these areas, with particular emphasis on the comparative value of various diagnostic procedures and the effect of therapy on prognosis. While controversy still exists concerning proper screening guidelines for the asymptomatic population, there is a growing consensus that some form of stress testing in high-risk individuals (ie, those with multiple coronary risk factors) is appropriate. Copyright © 2005 by Current Science Inc.

引用

页码：155 / 163

页数：8

共 79 条

[1]

Crea F., Pupita G., Glassi A.R., Et al., Role of adenosine in the pathogenesis of anginal pain, Circulation, 81, pp. 164-172, (1990)

[2]

Droste C., Roskamm H., Experimental pain measurement in patients with asymptomatic myocardial ischemia, J. Am. Coll. Cardiol., 81, pp. 164-172, (1983)

[3]

Sheps D.S., Adams K.F., Hinderliter A., Et al., Endorphins are related to pain perception in coronary artery disease, Am. J. Cardiol., 59, pp. 523-527, (1987)

[4]

Falcon C., Guasti L., Ochan M., Et al., Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia, J. Am. Coll. Cardiol., 22, pp. 1614-1620, (1993)

[5]

Marchant B., Umachandran V., Wilkinson P., Et al., Reexamination of the role of endogenous opiates in silent myocardial ischemia, J. Am. Coll. Cardiol., 23, pp. 645-651, (1994)

[6]

Mazzone A., Cusa C., Mazzucchelli I., Et al., Increased production of inflammatory cytokines in patients with silent myocardial ischemia, J. Am. Coll. Cardiol., 38, pp. 1895-1901, (2001)

[7]

Mazzone A., Mazzucchelli Vezzoli M., Et al., Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia, J. Am. Coll. Cardiol., 36, pp. 746-750, (2000)

[8]

Marchant B., Umachandran V., Stevenson R., Et al., Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetes, J. Am. Coll. Cardiol., 22, pp. 1433-1437, (1993)

[9]

McNulty P.H., Ettinger S.M., Gascho J., Et al., Comparison of subjective perception of myocardial ischemia produced by coronary balloon occlusion in patients with versus those without type 2 diabetes mellitus, Am. J. Cardiol., 91, pp. 965-967, (2003)

[10]

Rutter M.K., Wahid S.T., McComb J.M., Marshall S.M., Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes, J. Am. Coll. Cardiol., 40, pp. 56-61, (2002)

← 1 2 3 4 5 6 7 8 →